Amel Musa Taha

Title: Amel Musa Taha: Innovator in Nanotechnology and Cancer Research

Introduction

Amel Musa Taha is a prominent inventor based in Al-Ahsa, Saudi Arabia. She has made significant contributions to the fields of nanotechnology and cancer research, holding a total of 6 patents. Her innovative work focuses on developing advanced materials and methods that enhance catalytic processes and provide potential solutions for cancer treatment.

Latest Patents

One of her latest patents is titled "Method of forming metal oxide nanostructures on a TiO-ZnO-buffered substrate." This method involves creating TiO—ZnO nanoparticles coated with a copper (II) complex. The process includes forming a mononuclear copper complex by treating a ligand with Cu ions and immobilizing this complex on the nanoparticles. The resulting TiO—ZnO nanoparticles exhibit improved catalytic effectiveness, particularly in the oxidation of alcohols and decarboxylative bromination of acids, by reducing reaction time and temperature.

Another notable patent is the "Effective anticancer drug candidate of dinuclear palladium (II) bis-dihydrozone malonyl complex." This invention details the synthesis of a dinuclear palladium (II) bis-dihydrozone malonyl complex and its application as an anti-cancer agent. This work highlights her commitment to addressing critical health challenges through innovative chemical solutions.

Career Highlights

Amel Musa Taha is affiliated with King Faisal University, where she contributes to research and development in her areas of expertise. Her academic and professional journey reflects a dedication to advancing scientific knowledge and practical applications in nanotechnology and medicinal chemistry.

Collaborations

Throughout her career, Amel has collaborated with esteemed colleagues, including Mohamed Shaker Sayed Adam and Mohamed M Makhlouf. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Amel Musa Taha stands out as a leading inventor whose work in nanotechnology and cancer research has the potential to make a significant impact. Her innovative patents and collaborations reflect her commitment to advancing science and improving health outcomes.